Takeshi Okanoue

23.1k total citations · 3 hit papers
390 papers, 15.5k citations indexed

About

Takeshi Okanoue is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Takeshi Okanoue has authored 390 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 203 papers in Epidemiology, 175 papers in Hepatology and 73 papers in Molecular Biology. Recurrent topics in Takeshi Okanoue's work include Liver Disease Diagnosis and Treatment (173 papers), Hepatitis C virus research (81 papers) and Liver Diseases and Immunity (51 papers). Takeshi Okanoue is often cited by papers focused on Liver Disease Diagnosis and Treatment (173 papers), Hepatitis C virus research (81 papers) and Liver Diseases and Immunity (51 papers). Takeshi Okanoue collaborates with scholars based in Japan, United States and France. Takeshi Okanoue's co-authors include Yoshito Itoh, Toshikazu Yoshikawa, Masahito Minami, Yoshio Sumida, Yoshiki Murakami, Kohichiroh Yasui, Kei Kashima, Hironori Mitsuyoshi, Stephen A. Harrison and Arun J. Sanyal and has published in prestigious journals such as New England Journal of Medicine, Cell and Journal of Clinical Oncology.

In The Last Decade

Takeshi Okanoue

377 papers receiving 15.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

2020 1.3k citations Takeshi Okanoue, Arun J. Sanyal et al. profile →
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues

2005 946 citations Takeshi Okanoue et al. profile →
The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation

2007 726 citations Yoshito Itoh, Tomoaki Nakajima et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takeshi Okanoue Japan	60	8.7k	6.2k	3.9k	2.6k	2.3k	390	15.5k
Fabio Marra Italy	72	10.4k 1.2×	8.1k 1.3×	3.7k 1.0×	2.2k 0.9×	3.0k 1.3×	280	17.9k
Jean‐François Dufour Switzerland	56	8.5k 1.0×	7.7k 1.2×	3.0k 0.8×	1.7k 0.7×	2.1k 0.9×	342	14.4k
Michio Sata Japan	58	6.8k 0.8×	7.1k 1.1×	3.1k 0.8×	1.1k 0.4×	2.6k 1.2×	457	15.1k
Matthew M. Yeh United States	51	13.4k 1.5×	5.9k 1.0×	3.5k 0.9×	4.5k 1.8×	3.0k 1.3×	129	17.2k
Alastair D. Burt United Kingdom	60	12.2k 1.4×	8.5k 1.4×	2.7k 0.7×	3.8k 1.5×	3.2k 1.4×	238	18.4k
Jung‐Hwan Yoon South Korea	59	6.7k 0.8×	6.8k 1.1×	2.8k 0.7×	1.3k 0.5×	2.8k 1.2×	425	13.6k
James G. Kench Australia	50	6.4k 0.7×	3.7k 0.6×	2.6k 0.7×	1.9k 0.7×	2.5k 1.1×	168	11.9k
Michael Torbenson United States	66	12.7k 1.5×	9.2k 1.5×	5.8k 1.5×	3.0k 1.2×	4.0k 1.8×	297	22.7k
Ekihiro Seki United States	67	9.4k 1.1×	6.2k 1.0×	6.2k 1.6×	1.8k 0.7×	2.4k 1.1×	140	18.5k
Linda D. Ferrell United States	60	13.0k 1.5×	10.3k 1.7×	2.9k 0.7×	3.0k 1.2×	6.6k 2.9×	222	21.7k

Countries citing papers authored by Takeshi Okanoue

Since Specialization

Citations

This map shows the geographic impact of Takeshi Okanoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Okanoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Okanoue more than expected).

Fields of papers citing papers by Takeshi Okanoue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Okanoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Okanoue. The network helps show where Takeshi Okanoue may publish in the future.

Co-authorship network of co-authors of Takeshi Okanoue

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Okanoue. A scholar is included among the top collaborators of Takeshi Okanoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Okanoue. Takeshi Okanoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamaguchi, Kanji, Yusuke Takahashi, Hiroshi Ishiba, et al.. (2024). Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction. Scientific Reports. 14(1). 23993–23993. 7 indexed citations

Hayashi, Hideki, Yoshihiro Kamada, Hideki Fujii, et al.. (2023). Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology. 49(7). 1658–1664. 6 indexed citations

Seko, Yuya, Kanji Yamaguchi, Toshihide Shima, et al.. (2023). The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study. Liver International. 43(10). 2210–2219. 21 indexed citations

Sanyal, Arun J., Quentin M. Anstee, Michael Trauner, et al.. (2021). Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. Hepatology. 75(5). 1235–1246. 89 indexed citations

Umemura, Atsushi, Seita Kataoka, Aya Takahashi, et al.. (2021). Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress. Frontiers in Oncology. 11. 758549–758549. 9 indexed citations

Yamaguchi, Kanji, Yuya Seko, Hiroshi Ishiba, et al.. (2021). Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice. Laboratory Investigation. 102(3). 281–289. 42 indexed citations

Kamada, Yoshihiro, Hirokazu Takahashi, Masahito Shimizu, et al.. (2021). Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review. Journal of Gastroenterology. 56(12). 1045–1061. 28 indexed citations

Umemura, Atsushi, S Umemura, Seita Kataoka, et al.. (2021). Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. Cancers. 13(7). 1515–1515. 17 indexed citations

Younossi, Zobair M., Vincent Wai‐Sun Wong, Quentin M. Anstee, et al.. (2020). Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes. Hepatology Communications. 4(11). 1637–1650. 42 indexed citations

10.

Itoh, Yoshito, Takeshi Nishimura, Hiroaki Hashimoto, et al.. (2011). Simple formula to predict response to peginterferon alpha2b and ribavirin combination therapy in genotype 1 chronic hepatitis C patients with high viral loads. Hepatology Research. 41(2). 126–132. 1 indexed citations

11.

Minami, Masahito, et al.. (2010). Interferon and nucleoside analog combination therapy for hepatitis B. Clinical Journal of Gastroenterology. 3(2). 69–72. 1 indexed citations

12.

Kumada, Hiromitsu, Takeshi Okanoue, Morikazu Onji, et al.. (2010). Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatology Research. 40(1). 8–13. 81 indexed citations

13.

Nakajima, Tomoaki, Kohichiroh Yasui, Keika Zen, et al.. (2008). Activation of B‐Myb by E2F1 in hepatocellular carcinoma. Hepatology Research. 38(9). 886–895. 51 indexed citations

14.

Yoshida, Naoya, Kazuhiro Katada, Osamu Handa, et al.. (2007). Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. International Journal of Molecular Medicine. 19(2). 335–40. 57 indexed citations

15.

Umemura, Atsushi, Yoshito Itoh, Katsuhiko Itoh, et al.. (2007). Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology. 47(2). 493–502. 49 indexed citations

16.

Mitsufuji, Shoji, Yoichi Tatsumi, Naoki Wakabayashi, et al.. (2006). ARGON PLASMA COAGULATION : IN VI VO TISSUE DAMAGE TO THE ESOPHAGUS AND STOMACH AND CLINICAL EFFICACY FOR EARLY ESOPHAGEAL AND GASTRIC CANCER. Acta gastro-enterologica belgica. 48(6). 1259–1266. 1 indexed citations

17.

Katada, Kazuhiro, Norimasa Yoshida, Yutaka Isozaki, et al.. (2005). Prevention by Rebamipide of Acute Reflux Esophagitis in Rats. Digestive Diseases and Sciences. 50(S1). S97–S103. 21 indexed citations

18.

Iwai, Masaki, Akira Muramatsu, Saiyu Tanaka, et al.. (2002). Macroscopic and Microscopic Findings of Livers in Malignant Hematologic Disorders, Biopsied Under Peritoneoscopy. Journal of Clinical Gastroenterology. 35(3). 262–265. 4 indexed citations

19.

Kashima, Kenji, Yasunobu Itoh, M Minami, et al.. (1999). Fetal DNA in peripheral blood mononuclear cells from female patients with primary biliary cirrhosis.. Hepatology. 30(4). 473. 2 indexed citations

20.

Mitsuyoshi, Hironori, Toshiaki Nakashima, Yoshio Sumida, et al.. (1999). Ursodeoxycholic Acid Protects Hepatocytes against Oxidative Injury via Induction of Antioxidants. Biochemical and Biophysical Research Communications. 263(2). 537–542. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact